RxDoctor Payments Data

John Thrash

Foot & Ankle Surgery · Pine Bluff, ARNPI 1811973225

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $2,750 of the $3,155 with a category attached, or 87.2%. 22 manufacturers reported payments, led by Smith+Nephew at 38.8% of the total.

$3,155in general payments, 2019–2025

Across 104 payments — averaging $30.34 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$1K
  • Paratek Pharmaceuticals, Inc.$599
  • AbbVie$225
  • Convatec Inc.$178
  • Kerecis Limited$149
  • Treace Medical Concepts, Inc.$143
  • plus $639 from 16 others

What the payments were for

  • Travel & lodging$40513%
  • Food & beverage$2,75087%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,155 in reported general payments places this provider in the 55th percentile of 35 foot & ankle surgery providers in Arkansas.

See all foot & ankle surgery providers in Arkansas

Medicare billing

Part B allowed, 2024
$113,601
Medicare patients
392
Services billed
1,588

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Gabapentin81$632
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav40$523
Allopurinol53$253
Doxycycline Hyclate12$248
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen28$148
Naproxen22$129
Cephalexin11$85
Diclofenac Sodium13$76

Paid to pharmacies, not to this prescriber.

Other foot & ankle surgery in Pine Bluff

See the full list for Arkansas

Where these figures come from

Is this you, or does something look wrong? →